Actively Recruiting
Thumb Hemi-Arthroplasty With Natural Kinematics; a Prospective Multicenter Study to Confirm the Safety and Efficacy of the InDx Implant
Led by Loci Orthopaedics · Updated on 2025-09-03
73
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, multicentric non-comparative confirmatory study to evaluate the safety and performance of the InDx CMC implant for the treatment of CMC joint arthritis.
CONDITIONS
Official Title
Thumb Hemi-Arthroplasty With Natural Kinematics; a Prospective Multicenter Study to Confirm the Safety and Efficacy of the InDx Implant
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The patient is at least 18 years of age
- The patient has a confirmed Grade I-III osteoarthritis of the CMC joint on clinical examination and X-ray
- The patient is eligible for surgical treatment of CMC I arthrosis in the opinion of the investigator
- The patient agrees to abstain from enrolment in any other clinical trials that conflict or interfere with this study's results
- The patient is able to understand the aims and objectives of the trial and is willing to consent
- The patient is willing and able to return for all study-related follow-up procedures
- If female, the patient is either using contraception, postmenopausal, or has a male partner using contraception
You will not qualify if you...
- The patient is suffering from Rheumatoid arthritis in the index hand
- The patient is suffering from Grade IV osteoarthritis of the CMC joint
- The patient is suffering post-traumatic arthritis of the CMC joint in the index hand
- The patient is a pregnant or lactating female
- The patient has active or latent infection, or sepsis
- The patient has insufficient quantity or quality of bone and/or soft tissue in the index hand
- The patient has metal or polymer material sensitivity
- The patient has muscular imbalance, peripheral vascular disease that prohibits adequate healing, poor soft-tissue envelope, absence of musculoligamentous supporting structures, or peripheral neuropathy
- The patient has had previous thumb surgery in the index hand
- The patient has any medical condition deemed unsuitable by the investigator, including injury interfering with healing or significant systemic disease or infection
- The patient has undergone systemic corticosteroid, antineoplastic, immunostimulating, or immunosuppressive therapy within 30 days prior to implantation
- The patient has comorbidity reducing life expectancy to less than 36 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Az Sint-Jan Brugge AV
Bruges, Belgium, 8000
Actively Recruiting
Research Team
L
Liesbet Noë
CONTACT
J
Joke Denolf
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here